- Home
- IVP vs PALI Comparison
IVP vs PALI Comparison
Compare IVP & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVP
- PALI
- Stock Information
- Founded
- IVP 2020
- PALI 1996
- Country
- IVP United States
- PALI United States
- Employees
- IVP N/A
- PALI N/A
- Industry
- IVP Diversified Commercial Services
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IVP Miscellaneous
- PALI Health Care
- Exchange
- IVP Nasdaq
- PALI Nasdaq
- Market Cap
- IVP 3.0M
- PALI 3.4M
- IPO Year
- IVP 2023
- PALI N/A
- Fundamental
- Price
- IVP $2.08
- PALI $0.94
- Analyst Decision
- IVP
- PALI Strong Buy
- Analyst Count
- IVP 0
- PALI 2
- Target Price
- IVP N/A
- PALI $23.00
- AVG Volume (30 Days)
- IVP 139.9K
- PALI 192.2K
- Earning Date
- IVP 04-07-2025
- PALI 03-25-2025
- Dividend Yield
- IVP N/A
- PALI N/A
- EPS Growth
- IVP N/A
- PALI N/A
- EPS
- IVP N/A
- PALI N/A
- Revenue
- IVP $17,054,777.00
- PALI N/A
- Revenue This Year
- IVP N/A
- PALI N/A
- Revenue Next Year
- IVP N/A
- PALI N/A
- P/E Ratio
- IVP N/A
- PALI N/A
- Revenue Growth
- IVP 6.12
- PALI N/A
- 52 Week Low
- IVP $2.00
- PALI $0.89
- 52 Week High
- IVP $401.50
- PALI $9.65
- Technical
- Relative Strength Index (RSI)
- IVP 26.11
- PALI 24.22
- Support Level
- IVP $2.03
- PALI $0.95
- Resistance Level
- IVP $2.20
- PALI $1.08
- Average True Range (ATR)
- IVP 0.19
- PALI 0.09
- MACD
- IVP 0.07
- PALI -0.01
- Stochastic Oscillator
- IVP 11.19
- PALI 10.43
About IVP Inspire Veterinary Partners Inc.
Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.